Adam Richichi serves as the President and Chief Executive Officer of Archway Dental Partners, a multi-specialty dental platform headquartered in Danbury, Connecticut. With an MBA from Adelphi University, Richichi brings extensive leadership experience in the dental industry, including previous roles as CEO of Dental Associates of Connecticut (DACT) and founder of Novo Strategy Advisors.​

Under Richichi’s leadership, Archway Dental Partners has expanded its network to support over 70 dentists across more than 30 locations in Connecticut, offering integrated oral healthcare across all dental specialties . The organization emphasizes a partnership-driven model, focusing on clinical excellence and a collaborative culture.

In a recent episode of The Dental Economist Show, Richichi discussed strategies for scaling dental practices with a culture-first approach, the importance of work-life integration, and the role of technology in modern dentistry.

​For more information about Adam Richichi and Archway Dental Partners, you can visit archway.dental or view his professional profile on LinkedIn.

Dr. Alexander R. Vaccaro is an internationally acclaimed spine surgeon and the President of Rothman Orthopaedic Institute. He also serves as the Richard H. Rothman Professor and Chair of the Department of Orthopaedic Surgery at Thomas Jefferson University, where he holds joint appointments in orthopaedics and neurosurgery. A prolific researcher and educator, Dr. Vaccaro has authored more than 900 peer-reviewed publications and over 65 textbooks in the field of spine care.

Named the #1 global expert in spine surgery by Expertscape, Dr. Vaccaro is widely recognized for his contributions to spinal trauma, degenerative spine conditions, and minimally invasive techniques. He earned his medical degree from Georgetown University, completed residency at Thomas Jefferson University, and received fellowship training at the University of California, San Diego. He also holds a PhD in spinal trauma and an MBA from Temple University’s Fox School of Business.

In addition to his clinical leadership, Dr. Vaccaro is an entrepreneur and healthcare innovator, serving as CEO of Parkway Clinical Laboratories and managing partner at RBx Capital.

Amit Dhir is a healthcare entrepreneur and visionary leader with a strong track record of building and scaling innovative therapy services. He is the Founder and CEO of All Care Therapies, a rapidly growing provider of speech, occupational, and physical therapy solutions across multiple states. Under his leadership, the company has grown into a trusted network of over 300 therapists, delivering care through both in-person and telehealth platforms.

Prior to founding All Care Therapies, Amit launched and scaled one of the top SaaS platforms for the Applied Behavior Analysis (ABA) industry, which became the third-largest in its sector before being acquired by a private equity firm. He also co-founded SLP-tele, a leading digital speech therapy company, and manages the Dhir Family Office, which invests in healthcare and real estate ventures.

Amit holds a Master’s degree in Computer Science and brings a technology-forward mindset to healthcare delivery. Beyond his business ventures, he is committed to giving back through a nonprofit foundation focused on women’s financial literacy and children’s health.

Andre currently serves as Chief Executive Officer for the Illinois Bone and Joint Institute LLC, a multispecialty Orthopedic practice in the greater Chicago area.

The practice consists of approximately 165 Physicians with specialties in Orthopedics, Rheumatology, Pain Management, Physiatry, Podiatry and Geriatrics. IBJI also employs ~ 275 Physical and Occupational Therapists and 125 midlevel Providers with a total employee count of ~ 2,250. He reports directly to the Board of Managers of IBJI and supervises both strategic and operational aspects of the organization. IBJI has ~$300m in Clinical Revenues/year, with an additional ~$200m in Ancillary and ASC Income.

He serves on the Value Based Committee for the OrthoForum group and also oversees IBJI’s “OrthoSync” program, a convener organization that serves clients in CMS’s BPCI-A Model as well as CJR models on behalf of primarily Orthopedic Practices.

Previous to his CEO role, Andre served as Director of Ancillary and Value Based Medicine Service lines for IBJI. Along with these responsibilities, he was the CEO and Managing Member of Elevate LLC, a healthcare consulting and services company formed in 2010, specializing in Ancillary and Value service line initiation and expansion with specific alignment to Bundled Payment and Risk models and strategies.

Between 2005 and 2010 he was the Director of IBJI’s Rehabilitation Services network, the 3^rd largest outpatient Physical Therapy provider in the Chicagoland area.

Professional Philosophy

Andre’s professional passion focuses on modern day healthcare redesign strategies. He believes strongly in an “agile” management style so leaders can develop and function to their fullest capacity, and teams can adapt to rapid market fluctuations in a similar fashion.

He is an advocate for transformational and transparent activities beyond the current state of healthcare, along with a renewed mindset towards truly integrated practice patterns, all designed in a Patient centric manner.

From an actuarial perspective, Andre believes that the future models for effective healthcare delivery platforms are yet to be developed. As such, one has the ability to be truly creative and innovative, as long as you operate from a sound foundational platform. Data and Informatics are key determinants of success when effectively integrated with applied and timely execution of qualitative management decisions.

Growth creates strain – it is a normal component of healthy environments. The ability to navigate opportunities and simultaneously achieve consistent and optimal outcomes should always define organizational success.

   Additional

• Andre is also a frequent speaker in various forums, primarily centered around conceptual redesign of modern healthcare payment methodologies – both from a Federal as well as Commercial standpoint.
• During the period from 1996 to 2001, he was also a member of the United States National Rugby Team – first as a player, including 1999 Rugby World Cup Squad member and thereafter as part of the Coaching team at the 2003 RWC.
• Andre continues serving on USA Rugby’s Medical Advisory Board as of 2023
• Pastime favorites include Travel with his Family, Golf and College Sports.

Andrew Mintz is a seasoned healthcare executive with extensive experience in leading and transforming multi-specialty healthcare organizations. Currently serving as CEO of The Smilist Management, Andrew oversees over 60 state-of-the-art dental offices across the Northeast, driving patient satisfaction, innovation in clinical care, and the adoption of advanced technologies.

Previously, Andrew served as CEO of Pinnacle Fertility, where he set new standards for patient outcomes and operational efficiency in fertility care, and as CEO of Women’s Care, where he led value-based care transitions and expanded high-quality women’s health services across multiple states. With a proven track record of leadership, mergers and acquisitions, and operational excellence, Andrew continues to shape patient-centered, technology-driven healthcare solutions.

Anthony Milonas is the Chief Executive Officer of Ascend Aesthetic Partners, a management services organization (MSO) dedicated to advancing excellence in aesthetic medicine. With a career spanning over three decades, Milonas has held executive leadership roles across healthcare, logistics, and global operations.

Prior to his role at Ascend, Milonas served as President and CEO of Canadian Orthodontic Partners, Canada’s largest orthodontic dental support organization, where he led the expansion of over 72 affiliated practices across Canada and into the U.S. He also held executive positions at CBI Health Group, We Care Home Health Services, Barnes Group Inc., and DHL, gaining extensive experience in scaling healthcare and logistics businesses.

Milonas holds a Master’s Certificate in Healthcare Management from York University, an MBA in Marketing from Eastern Michigan University, and a BBA in Finance from Bishop’s University. He is fluent in English, French, and Greek, and actively participates in leadership organizations, including the Young Presidents’ Organization and the Canadian Abilities Foundation.

At Ascend Aesthetic Partners, Milonas focuses on building a collaborative network of top-tier plastic surgeons, enhancing patient care, and fostering innovation in aesthetic medicine.

Ben Sherman, CFA, has held executive roles within DocGo, including Executive Vice President of Corporate Development. In this capacity, he played a significant role in the company’s growth strategy, overseeing key acquisitions and partnerships. His background includes experience in financial management and corporate development across various organizations.

Burt Rubin is the Chief Executive Officer of Curalta Foot & Ankle, a leading integrated network of podiatry and foot and ankle care providers in the northeastern United States. Under his leadership, Curalta has expanded to 21 locations across New York and New Jersey, offering comprehensive services for a wide range of conditions, including sports injuries, pediatric podiatry, traumas, and fractures.

With a background in healthcare operations, Rubin has a demonstrated history of working in the industry, previously serving as a Chief Operating Officer . He holds a degree from New York University’s Stern School of Business.

Rubin’s vision for Curalta centers on uniting the fragmented podiatry industry to create an integrated offering for foot and ankle care, aiming to achieve better outcomes for patients . He emphasizes clinical excellence, care coordination, and outstanding customer service, fostering a team-based approach that benefits both patients and providers.

In 2023, Rubin led Curalta through a significant partnership with NewSpring and BPEA, securing investments to fuel continued growth and expansion . This strategic move aligns with Curalta’s mission to provide holistic, high-quality care throughout the course of patients’ lives.

Committed to professional development, Rubin has implemented programs that allow associates to own equity in Curalta, with 90% of associates being shareholders as of 2024 . This initiative reflects his dedication to fostering a collaborative and invested workforce.

W. Carl Whitmer is the Founder and Chief Executive Officer of ArchWell Health, a national healthcare organization dedicated to providing comprehensive, value-based primary care to adults aged 60 and older. Since its inception in March 2020, Whitmer has led ArchWell Health in its mission to enhance healthcare access and quality for seniors across the United States.

With over 25 years of executive leadership experience in healthcare services, Whitmer has a diverse background encompassing managed care, acute care, behavioral health, and physician practice management. His previous roles include serving as Chief Executive Officer at IASIS Healthcare from 2000 to 2017 and as an Operating Advisor at Clayton Dubilier & Rice from 2018 to 2020.

Under Whitmer’s leadership, ArchWell Health has rapidly expanded its footprint, opening multiple centers nationwide to meet the growing demand for senior-focused primary care. The organization’s approach emphasizes longer appointment times, integrated care teams, and community engagement to address the unique health needs of older adults.

Whitmer holds a Bachelor of Business Administration in Accounting from Western Kentucky University.

Chris Kane is the CEO of Allergy Partners, a role he assumed in September 2023. He has been deeply involved with the organization for the years prior as a board member, where he played a key role in facilitating its growth and transition from a physician-led platform to a family office-owned model. Prior to joining Allergy Partners, Chris served as CEO of West Dermatology from 2014 to 2021, leading the organization for seven years and driving its success in the dermatology sector.

Daniel E. Greenleaf is the Chief Executive Officer of Duly Health and Care, the largest
independent, multi-specialty physician-directed medical group in the nation. Duly has
more than 950 primary care and specialty physicians and approximately 6,000 team members, in over 190 locations; serving one million patients in greater Chicagoland. The Duly
Health and Care brand encompasses three medical groups – DuPage Medical Group,
Quincy Medical Group and The South Bend Clinic and includes five Ambulatory Surgery
Centers, five labs and 58 infusion chairs. Our value-based care service line provides
integrated care for 230,000 partial risk and 100,000 full risk lives (Medicare Advantage and
ACO Reach).
Dan is a six-time healthcare CEO including prior roles as President and CEO of Modivcare;
President and CEO of BioScrip, Inc.; Chairman and CEO of Home Solutions Infusion Services; and President and CEO of Coram Specialty Services.
Dan graduated from Denison University with a Bachelor of Arts in Economics and holds
a Master of Business Administration in Health Administration from the University of Miami.
A military veteran, he was a captain & navigator in the United States Air Force & served in
Operation Desert Storm.

Dave’s views on DSO market trends, strategy and execution are informed by his uniquely holistic vantage point having served in a variety of roles across a number of DSOs including: CEO; COO; CAO, CIO; and leadership roles within dental RCM, specialty operations, and lab service lines. Dave joined Absolute Dental in 2016.  Absolute Dental operates nearly 40 practices across Nevada, and today is proudly the largest Medicaid provider in Nevada.  Absolute Dental also offers holistic dental care under the mantra of “all dentistry one place,” to help deliver high quality, coordinated care to patients as efficiently and conveniently as possible.

In addition to his CEO and Chairman role at Absolute Dental, Dave also serves as board director of Great Expressions Dental Centers and is an active participant on the investment committee at Dental Innovation Alliance (DIA).

David Young serves as the President and Chief Executive Officer of Unified Women’s Healthcare, a leading women’s health company in the United States. In his role, he oversees the organization’s strategic direction and operations, aiming to enhance healthcare delivery for women nationwide.

Before joining Unified Women’s Healthcare, Mr. Young held several executive positions in the healthcare sector. He was the Global CEO of GenesisCare, an international oncology services provider operating in Australia, the United States, the United Kingdom, and Spain. Additionally, he served as President and CEO of Physicians Endoscopy, Inc., a gastrointestinal investment and management services provider for independent GI providers. His previous roles also include Chief Operating Officer of Privia Health, Inc., Chief Financial Officer of Smile Brands, Inc., and senior leadership positions at McKesson Specialty Health and US Oncology, Inc.

Originally from Scotland, Mr. Young holds a Bachelor of Arts degree in Accounting with Honors and an MBA from the University of Strathclyde in Glasgow. He is also a Chartered Financial Analyst (CFA), Certified Public Accountant (CPA), Chartered Accountant (CA), and Corporate Treasurer.

Dr. Scott Wise, a U.S. Army veteran, is President and Chief Executive Officer for Valor Healthcare, Inc. A graduate of the University of Texas Southwestern Medical School at Dallas, he also holds an MBA with a Focus in Healthcare Administration from the Isenberg School of Management at UMass Amherst.

After leaving the Army in 1998, Dr. Wise was in private medical practice for 10 years before joining Valor in 2007. He has held successive roles at Valor beginning as a Clinic Medical Director before being named the company’s Chief Medical Officer/Chief of Staff, Chief Operating Officer, and now President/CEO since 2014.

Erez I. Meltzer serves as the Chief Executive Officer and Acting Chairman of the Board at Nano-X Imaging Ltd. (Nanox), a company dedicated to transforming medical imaging through innovative technologies. He assumed the CEO role in late 2021, following two years as a board member.

With over 35 years of leadership experience, Mr. Meltzer has held executive positions across various global industries. His previous roles include Chairman of the Board at Hadassah Medical Center in Israel for six years, and leadership positions at companies such as Gadot Chemicals & Shipping Group, Africa Israel, Netafim, and Creo Scitex.

Mr. Meltzer’s educational background includes undergraduate studies at The Hebrew University of Jerusalem and master’s degrees in Business Administration from both Boston University and Ben-Gurion University of the Negev.

Under his leadership, Nanox focuses on making advanced medical imaging more accessible and affordable worldwide, aiming to improve early disease detection and healthcare outcomes.

Geoff Wayne is a seasoned executive with extensive leadership experience in healthcare organizations. He currently serves as the CEO of Jefferson Dental & Orthodontics. Geoff also holds the position of Executive Chairman at Advantage Surgical and Wound Care, where he has been instrumental in guiding the company since 2022.

In addition to his executive roles, Geoff has served as a board member for various private equity-backed businesses, including Encore Infusion, and remains an active member of YPO Dallas. With a track record of driving growth and operational excellence, Geoff is a trusted leader in the healthcare and private equity sectors.

Dr. James Gohar is on a mission to transform women’s healthcare into what it should be—personal, empowering, and all-encompassing. At Viva Eve, he has created a warm, welcoming space that offers integrated specialty care, including comprehensive Ob/Gyn services, fibroid care, minimally invasive gynecologic surgery, nutrition, vein procedures, and cosmetic dermatology—all under one roof.

With over 20 years of experience and his visionary entrepreneurial drive, Dr. Gohar has built a practice rooted in innovation and compassion. Patients love his warmth, attention to detail, and genuine ability to listen, ensuring every woman feels heard and cared for. Whether guiding patients on their health journey or helping them feel confident in their own skin, Dr. Gohar’s dedication is evident in everything he does. He is proud to be included in the2024-2025 SCALE Community – Most Influential Healthcare Leaders list.

Dr. James Weber is the founder and Chief Executive Officer of GI Alliance, the largest independent gastroenterology practice network in the United States. Under his leadership, GI Alliance has expanded to encompass over 800 physicians across more than 400 locations nationwide, delivering comprehensive, patient-centered digestive health care.

Dr. Weber’s medical journey began with a degree in Biomedical Science from Texas A&M University, followed by a medical degree from the University of Texas Southwestern Medical School in Dallas. He completed his residency in internal medicine at Parkland Memorial Hospital and a gastroenterology fellowship at Baylor University Medical Center.

In 1995, Dr. Weber founded Texas Digestive Disease Consultants (TDDC), which grew to become the nation’s largest gastroenterology group under his leadership. TDDC was the first practice to join GI Alliance when it was established in 2018.

Beyond his executive roles, Dr. Weber is an active clinician specializing in inflammatory bowel diseases, including Crohn’s disease and ulcerative colitis. He continues to see patients at GI Alliance’s Lone Star Endoscopy in Southlake, Texas.

Dr. Weber also serves as President and Board Chair of the Digestive Health Physicians Association (DHPA), a national advocacy organization representing over 2,300 gastroenterologists. He is affiliated with several professional societies, including the American Gastroenterological Association, the American College of Gastroenterology, and the American Society for Gastrointestinal Endoscopy.

Recognized for his contributions to the field, Dr. Weber has received accolades such as “Doctor of the Year” from the Crohn’s and Colitis Foundation of North Texas, and has been named among the “Best Doctors in Dallas” by D Magazine and “Top Doctors in Tarrant County” by Fort Worth Magazine.

Through his visionary leadership, Dr. Weber has advanced GI Alliance’s mission to provide high-quality, physician-led, and patient-first gastroenterology care across the nation.

Jason Madsen is the Founder and Chief Executive Officer of Ascend Medical, a healthcare company based in Atlanta, Georgia, that specializes in delivering comprehensive, in-network primary care through a hybrid model combining virtual, mobile, and in-home services. Established in 2020, Ascend Medical offers a range of services, including primary care, pediatrics, behavioral health, urgent care, and chronic disease management, aiming to provide accessible and patient-centered care.

Prior to founding Ascend Medical, Madsen co-founded WellStreet Urgent Care, a national urgent care platform that partnered with major health systems and grew into a company valued at over $1 billion. He also serves as the Managing Director of Madsen Capital Group, a private equity firm focused on healthcare services and related real estate investments.

Madsen holds a Bachelor of Arts in Political Science from the University of Colorado at Colorado Springs and an MBA in Finance from Columbia Business School. Beyond his professional endeavors, he is actively involved in community service, serving as the Chair of the Board of Trustees at The Ron Clark Academy, an innovative middle school in Atlanta.

Jeff Staser is the Chief Financial Officer (CFO) of Straine Dental Management (SDM), a rapidly growing dental support organization (DSO) headquartered in Sacramento, California. With a career spanning over three decades in healthcare finance and operations, Staser has been instrumental in SDM’s expansion across the United States.

Since its inception in April 2022, SDM has experienced significant growth under Staser’s financial leadership. The organization expanded from 33 practices in 11 states to 39 practice owners by 2023, positioning SDM to achieve over $200 million in revenue by the end of 2024. This impressive trajectory earned SDM a spot on the Inc. 5000 list of fastest-growing private companies in America for two consecutive years, with a three-year revenue growth of 185% .

Staser’s strategic approach focuses on empowering dental practice owners by preserving their autonomy while providing robust operational support. He emphasizes the importance of data-driven decision-making, strategic succession planning, and maximizing practice equity. His insights into the evolving DSO market and the impact of private equity have been featured in industry discussions, highlighting his expertise in navigating the complexities of dental practice management .

In addition to his role at SDM, Staser is the owner of JJ Outlet, demonstrating his entrepreneurial spirit and commitment to business growth .

Through his leadership, Jeff Staser continues to shape the future of dental support organizations, fostering a culture of excellence and innovation within Straine Dental Management.

Kshitij Mohta leads Egon Zehnder’s work at the intersection of Health and Private Equity in the US. He collaborates with a diverse range of firms, from growth equity to large buyout entities, encompassing various investment sizes and strategies. He serves both sponsors and portfolio companies, addressing a spectrum of roles from Board and C-Level to VP positions, as well as tackling organizational challenges. His passion lies in guiding companies and exceptional leaders through their most challenging and vulnerable decisions, ensuring they receive the support necessary to make a significant impact on healthcare. Kshitij is deeply immersed in the healthcare ecosystem and its intersections across stakeholders and related sectors, engaging with both industry disruptors and the entities they aim to challenge.

Egon Zehnder is the world’s preeminent leadership advisory firm, inspiring leaders to navigate complex questions with human answers. The firm’s 600+ consultants across 66 offices and 36 countries are former industry and functional leaders who collaborate seamlessly to deliver the full power of the Firm to every client.

Prior to joining Egon Zehnder, Kshitij was with McKinsey & Company in New Jersey and Mumbai as an Associate Partner focusing on healthcare and private equity and helping clients with growth strategy, strategic transformations and turnarounds, and M&A. Earlier he worked at NBC Universal and its service provider, Genpact, in Bangalore and New York. Before moving to the United States, Kshitij lived and worked in India, Thailand, Germany, and the United Kingdom. Alongside his consulting work, Kshitij supports nonprofit organizations in India and serves on the advisory board of NJ LEEP, a college access and success program serving students and families in the greater Newark area.

Lew Little joined Giving Home Health Care in August 2022 as President and CEO. Giving Home is a health care coordinator and chronic care manager dedicated to advocating for and serving individuals with conditions contracted while working in nuclear energy programs for the Department of Energy.   Through the EEOICPA and RECA programs, Giving Home coordinates care in eight states. 

Before joining Giving Home, Little had been involved in the healthcare industry for over 20 years.  During that time, he served as CEO and Co-Founder of Harden Healthcare.  Harden initially operated as a long-term care company and later expanded into a post-acute company by incorporating home care services including Medicaid Home Health, Medicare Home Health and Hospice.  At the time of the sale of the home care business to Gentiva in 2013, the company’s revenue had grown to $800 million with 230 locations in fifteen states.  After Harden, Little was CEO of Covenant Surgical Partners for over four years as the company experienced rapid growth.  He also served as the Executive Chair of a healthcare SPAC that raised $220 million but was unable to find a suitable target and returned the capital to shareholders.  Finally, Little has served on several healthcare service companies and numerous not for profit Boards.

Little began his career in commercial banking and spent 18 years in that industry.  A native of Austin, he resides there with his wife of over 40 years, three married children, and six grandchildren.

Dr. Lewis Gold is the Co-Founder and Chairman of the Board of Advanced Recovery Systems (ARS), a physician-led behavioral healthcare company specializing in the treatment of substance use disorders, eating disorders, and co-occurring mental health conditions.

Dr. Gold co-founded ARS in December 2013 alongside Dr. Mitchell Eisenberg. Under their leadership, ARS has grown into a national network of treatment centers, including The Recovery Village facilities across the United States. The organization is dedicated to providing evidence-based, compassionate care, and has treated over 65,000 individuals since its inception.

Prior to ARS, Dr. Gold co-founded Sheridan Healthcare in 1994, where he served as Executive Vice Chairman and on the Board of Directors. During his tenure, he played a pivotal role in expanding the company from a single local practice to a national presence in 23 states. He was instrumental in multiple financial transactions, including an IPO in 1995 and several private equity sales.

Dr. Gold earned his medical degree from Temple University School of Medicine in 1982 and completed his anesthesia residency at the University of Miami’s Jackson Memorial Hospital. He is board-certified in anesthesiology.

Beyond his roles at ARS and Sheridan Healthcare, Dr. Gold has been involved in various healthcare ventures, including serving as an Operating Partner for J.W. Childs and joining the Board of Managers at Cano Health.

Dr. Gold’s extensive experience in healthcare management and his commitment to improving behavioral health services have made him a prominent figure in the industry.

Marcello J. Celentano is a seasoned healthcare executive with over 35 years of experience in business management and leadership. He currently serves as the Chief Executive Officer of Panorama Eye Care LLC, a physician-led management services organization based in Fort Collins, Colorado. In this role, he supports doctors in growing their businesses, creates strategic growth initiatives, and oversees responsibilities to allow physicians to focus on patient care.

Prior to his current position, Mr. Celentano held several executive roles in the healthcare industry. He served as the CEO of Connect Hearing, Inc. from 2011 to 2014 and led Claris Vision from 2014 to 2018. Earlier in his career, he was the Senior Vice President of Operations at LCA-Vision, Inc. from 2008 to 2011.

Mr. Celentano’s career began in the retail sector, where he held various management positions at Enterprise Rent-A-Car and FedEx Kinko’s, earning multiple leadership awards for his performance.

He holds a Bachelor of Arts in Business Administration from Washington State University and a Master of Business Administration in International Business and Corporate Entrepreneurship from Babson College.

Throughout his career, Mr. Celentano has been recognized for his expertise in building and leading management teams, developing functional infrastructure, and ensuring best-in-class patient experiences.

In addition to his professional endeavors, Mr. Celentano has served on the boards of various organizations, including the Ear Professionals International Corporation and the National Association of Specialty Health Organizations.

Mark Cuban is a renowned entrepreneur, investor, and philanthropist, widely recognized for his role as the co-founder of the Mark Cuban Cost Plus Drug Company (commonly known as Cost Plus Drugs). Launched in January 2022, this public-benefit corporation aims to revolutionize the pharmaceutical industry by offering affordable medications through a transparent pricing model. By eliminating intermediaries like pharmacy benefit managers, the company provides drugs at the manufacturer’s cost plus a 15% markup, a $5 pharmacy service fee, and a $5 shipping fee, ensuring significant savings for consumers

Cuban’s venture into the pharmaceutical sector was sparked by a cold email from Dr. Alex Oshmyansky, a radiologist and mathematician who proposed an online pharmacy to reduce drug prices. Impressed by the concept, Cuban invested in the idea, leading to the establishment of Cost Plus Drugs, with Dr. Oshmyansky serving as CEO

Beyond Cost Plus Drugs, Cuban is known for his ownership of the NBA’s Dallas Mavericks and his role as a prominent investor on the television show “Shark Tank.” His commitment to innovation and consumer advocacy continues to drive his endeavors across various industries.

Mark Lamp serves as the Chief Executive Officer of Adult & Pediatric Dermatology (APDerm), a leading integrated dermatology practice headquartered in Acton, Massachusetts. APDerm offers comprehensive medical, surgical, and cosmetic dermatology services across Massachusetts, New Hampshire, and Rhode Island.

With over 30 years of experience in the healthcare industry, Mr. Lamp has held leadership roles in various healthcare organizations. He holds a Bachelor of Science and a Master of Science in Electrical and Biomedical Engineering from Purdue University, as well as an MBA in Marketing and Strategy from San Jose State University.

Under Mr. Lamp’s leadership, APDerm has expanded its reach and services, emphasizing high-quality, patient-centric dermatology care. In partnership with Waud Capital Partners, the organization has focused on strategic growth while maintaining its commitment to patient care.

Mr. Lamp’s extensive experience and strategic vision continue to drive APDerm’s mission to provide exceptional dermatological care throughout the New England region.

Marshall Maran is the Co-Founder and Chief Executive Officer of M2 Orthopedics (M2O), a practice management firm dedicated to supporting and scaling leading orthopedic practices across the United States. With over 30 years of experience in healthcare services, Maran has focused on enhancing physician-led care models, particularly in the orthopedic sector.

Before establishing M2O, Maran was the founding CEO of Muve Health, a tech-enabled healthcare delivery organization specializing in total joint replacement surgeries. His leadership at Muve Health emphasized the integration of technology and patient-centered care in surgical facilities.

At M2 Orthopedics, Maran’s vision centers on empowering orthopedic surgeons by providing them with the resources and support necessary to maintain clinical autonomy while achieving sustainable growth. Under his guidance, M2O has secured significant funding to acquire and partner with prominent orthopedic practices, such as the Anderson Orthopaedic Clinic in Virginia.

Maran holds a Bachelor of Science in Health Policy & Administration from Penn State University and a Master of Science in Management from the University of Pennsylvania.

Through his leadership at M2 Orthopedics, Maran continues to advocate for innovative practice management solutions that prioritize physician leadership and patient care excellence.

Dr. Meena Seshamani, MD, PhD, is a distinguished physician, health economist, and policy expert currently serving as the Secretary of the Maryland Department of Health under Governor Wes Moore’s administration. In this role, she leads a department comprising approximately 9,000 employees and oversees a budget exceeding $20 billion, encompassing public health, Medicaid, behavioral health, and disability services across the state.

Prior to her current position, Dr. Seshamani was the Deputy Administrator and Director of the Center for Medicare at the Centers for Medicare & Medicaid Services (CMS). There, she managed the Medicare program, which provides health coverage to over 64 million Americans. Her tenure was marked by significant initiatives, including the implementation of the Medicare Drug Price Negotiation program and reforms to the Physician Fee Schedule to support holistic care services.

Dr. Seshamani’s academic credentials include a Bachelor of Arts in Business Economics from Brown University, a Doctor of Medicine from the University of Pennsylvania School of Medicine, and a PhD in Health Economics from the University of Oxford, where she was a Marshall Scholar. She completed her residency in Otolaryngology-Head and Neck Surgery at Johns Hopkins University School of Medicine and has practiced as a head and neck surgeon at institutions such as Kaiser Permanente in San Francisco and MedStar Georgetown University Hospital.

Her career also encompasses significant policy experience, including serving as Director of the Office of Health Reform at the U.S. Department of Health and Human Services during the Obama administration, where she led the implementation of the Affordable Care Act.

Dr. Seshamani is recognized for her commitment to advancing health equity, expanding access to care, and promoting sustainable, patient-centered healthcare delivery systems.

Michael Pennington is the Co-Founder and Chief Executive Officer of Platinum Dermatology Partners, a physician-led dermatology management organization headquartered in Dallas, Texas. Since its founding in 2016, Pennington has guided the company’s growth into a network of over 400 providers across five states, focusing on empowering dermatologists through operational support while preserving clinical autonomy.

Pennington’s professional background includes over 15 years in middle-market investment banking, with expertise in mergers and acquisitions and capital raising advisory. He has held positions at firms such as Accenture and Hilltop Securities Inc.

He holds a Bachelor of Business Administration in Finance from Baylor University and an MBA in Strategy and Entrepreneurship from Southern Methodist University’s Cox School of Business.

Under Pennington’s leadership, Platinum Dermatology Partners has emphasized a physician-centric model, fostering a culture of collaboration and excellence. The organization provides resources such as human resources, marketing, and compliance support, allowing physicians to focus on patient care.

Pennington is known for his commitment to building a culture of excellence, often using the hashtag #BeExceptional to highlight the organization’s dedication to high standards in dermatology.

Mindy Eng, MSN, RN, NE-BC, is a healthcare executive focused on elevating value through operational excellence, organizational growth, and financial stability. Starting her career as a registered nurse, she understands that quality patient care and exceptional clinical outcomes are second to none while achieving these goals. Mindy’s experience includes senior administrative roles in academic medical centers, equity backed startup, and M&A platforms. Prior to assuming the CEO role, she served as the Chief Operating Officer for MD Alliance Solutions, LLC with a two-year tenure. Her preceding position was Chief Operating Officer at New Hope Fertility Center, a multinational fertility center. In this role her focus was to streamline operations and provide structure for outside investment. Mindy holds a master’s degree in nursing, nurse executive board certification, and prior appointment as an adjunct professor for Rutgers School of Nursing.

Patrick Feeney is the Founder and Chief Executive Officer of Pearl Medical, a healthcare management company specializing in the development and operation of outpatient cardiovascular centers across the United States. Established in 2021, Pearl Medical has successfully launched over 100 outpatient-based labs (OBLs) and ambulatory surgery centers (ASCs) in 22 states, providing turnkey solutions that enable physicians to deliver high-quality care outside of traditional hospital settings.

Feeney’s inspiration for founding Pearl Medical stemmed from his desire to improve the clinical experience for physicians, influenced by his father’s career as an interventional cardiologist. Recognizing the challenges faced by healthcare providers, he aimed to create a more enjoyable and equitable environment for delivering patient care.

Prior to establishing Pearl Medical, Feeney had a successful career in investment management, focusing on healthcare and other sectors. He holds a JD-MBA from Northwestern University and a BA from Cornell University.

Under Feeney’s leadership, Pearl Medical has been recognized for its impact in the healthcare industry, with Feeney named among the 2024–2025 Most Influential Leaders by SCALE Healthcare.

Patrick Moore, Founder and President of CRNA Together and ARK Staffing Solutions.  Both companies started in January of 2021 but today have a combined revenue of nearly $100 million dollars.  I’ve been in healthcare staffing for over 24 years and have been proud to create and lead three healthcare staffing companies over the past decade.  CRNA Together and ARK Staffing Solutions are separate companies but share many of the same resources as both companies collaborate together to help healthcare systems and hospitals with Bridge Staffing Anesthesia programs.  

CRNA Together is a niche company that only focuses on 1099 staffing of CRNA’s for our anesthesia clients.  Those same anesthesia clients often need MD/DO anesthesiologist staffing for their programs and ARK Staffing supplies and manages 1099 physician anesthesiologists.  Combined, the two companies are changing healthcare by providing a fractured anesthesia staffing industry with both short and long-term staffing solutions.  Our Bridge Staffing Programs with our current clients are supplying between 12 points of service per day to as many of 40 points of anesthesia service per day.

Pelu Tran is the Co-Founder and Chief Executive Officer of Ferrum Health, a San Francisco-based healthcare technology company dedicated to improving patient outcomes through the deployment of artificial intelligence (AI) in clinical settings. Under his leadership, Ferrum Health has developed a secure enterprise AI platform that enables health systems to integrate and manage AI applications, facilitating early detection of diseases and reducing diagnostic errors.

Tran’s journey into healthcare entrepreneurship began during his studies at Stanford University, where he pursued both engineering and medicine. Four months before completing his medical degree, he made the pivotal decision to leave medical school to co-found Augmedix, a company that utilized Google Glass technology to streamline medical documentation. As Chief Commercial Officer, Tran played a crucial role in expanding Augmedix to over 1,000 employees across five countries, serving more than half of the largest health systems in the United States and generating $20 million in annual revenue.

The loss of his uncle to a preventable medical error in 2018 profoundly influenced Tran’s mission to enhance diagnostic accuracy in healthcare. Recognizing the potential of AI to identify such errors, he founded Ferrum Health to bridge the gap between innovative AI solutions and their practical application in healthcare systems. The platform has since analyzed over 500,000 unique patient records, demonstrating its impact on patient safety and care quality.

Tran’s contributions to healthcare innovation have been recognized globally. He has been named a Technology Pioneer by the World Economic Forum, a Fellow of the United Nations World Summit on Innovation, and was listed in Forbes’ Healthcare 30 Under 30. Beyond his entrepreneurial endeavors, Tran shares his expertise by guest lecturing at institutions such as UC Berkeley, UCSF, and Stanford, focusing on healthcare leadership and innovation.

In 2024, Ferrum Health secured a $16 million Series A funding round, underscoring investor confidence in the company’s vision to democratize access to clinical AI technologies and enhance patient care across health systems.

Award winning Sales and Marketing Executive in the Healthcare sector who created, built and managed executive sales team to drive market share and profitability. Expertise in Private Equity Organizations and corporate re-engineering. Proven success in navigating Healthcare C-Suite leaders and presenting value in Healthcare Technology Solutions and identifying methods to improve profitability and patient satisfaction.

Results driven and proven architect of start-up organizations. A combination of entrepreneurial spirit and proven strategic business building that enables organizations to turn-around their results and flourish in the marketplace. Strong track record of consistently achieving objectives, goals and business plans. Possesses excellent people, communication, organizational, and analytical skills. Enthusiastic professional executive with extensive diversified experience in professional and program development identifying opportunities to maximize human potential and financial growth. Experienced business thinker who provides an outside examination of all facets of the business to help drive the next steps to success.

Rezwan Manji is the Co-Founder and Chief Executive Officer of Imagen Dental Partners, a Scottsdale, Arizona-based Dental Partnership Organization (DPO) dedicated to supporting high-performing, technology-driven dental practices. With over 15 years of experience in the dental industry, Manji established Imagen to empower dentists to maintain clinical autonomy while benefiting from comprehensive business support and shared resources.

Prior to founding Imagen, Manji held several leadership roles at Spear Education, a prominent dental education company. As President, he led the transformation of Spear’s traditional campus-based model into a leading digital education platform, serving over 16,000 members. He also spearheaded the development of Spear Practice Solutions, a technology-enabled consulting and analytics service aimed at enhancing practice growth.

Manji’s educational background includes a Bachelor of Commerce in Entrepreneurial Management from Royal Roads University and an MBA in Entrepreneurship from Arizona State University’s W. P. Carey School of Business.

Beyond his professional endeavors, Manji is actively involved in his community. He is a partner in Phoenix Rising FC, a professional soccer club in Arizona, and a member of the Young Presidents’ Organization (YPO), a global network of chief executives. His philanthropic efforts include support for organizations such as the Open Wide Foundation, Make-A-Wish Foundation, and HopeKids.

Under Manji’s leadership, Imagen Dental Partners has emerged as one of the fastest-growing DPOs in the country, fostering a collaborative environment where dentists can focus on delivering exceptional patient care while achieving sustainable growth.

With more than 40 years of knowledge and executive experience in Fortune 500 and private healthcare services companies, Richard “Rick” Hall provides visionary leadership and strong strategy execution. A former U.S. Marine, Mr. Hall has a unique combination of organization, discipline, leadership skills and wisdom to help companies reach their goals. In addition, he has a proven track record of building high-performing teams and is a natural networker, seamlessly connecting people together.

Mr. Hall joined USOSM as president and CEO in February of 2018 as employee No. 3 and has shepherded the company through its early growth and continued development, helping to shape USOSM’s vision and trajectory. Under his leadership, USOSM has grown to include 99 partner practices, 225 surgeons, with 197 clinical locations, across 26 states. The company completed a very successful recapitalization event in 2021.

Previously, Mr. Hall served as president and CEO of Oncology Services International, the world’s largest independent service organization specializing in radiation therapy equipment. Mr. Hall guided the company through a significant transformation and successful sale to a prominent, private equity firm. Over the course of his career, he has held 9 executive level roles in venture capital or private equity organizations and has worked with 13 different firms.

He served as president of Alliance Oncology and senior vice president of business development, marketing and physician recruitment for US Oncology. Prior to that, he served as COO of PatientKeeper, president of the acute care division at McKesson Corporation and owner/chairman of BrightStar Care. Mr. Hall began his career with American Hospital Supply, a company well respected for developing healthcare services leaders.

Mr. Hall currently serves on the Board of US Oral Surgery Management and Sevaredent. In addition, he is a member of the Executive Commmittee of the ADSO and Healthcare Services Advisory Council for Riverglade Capital.

Mr. Hall is involved with several nonprofit organizations and is a board member with Christine’s Hope for Kids. He actively supports causes that support veterans and the families of fallen and disabled service members, including Folds of Honor, The Marine Corps Scholarship Foundation and Operation Restore Oral Health. In addition, he was recently recognized with the Patriot Award from the U.S. Office of the Secretary of Defense and the Employer Support of the Guard and Reserve. The award honors individuals and companies that actively support employee participation in America’s National Guard and Reserve.

Mr. Hall earned his bachelor’s degree in healthcare administration from Penn State University. In addition, he is a graduate of the executive healthcare program at Duke University.

Rivka Friedman is a prominent healthcare leader serving as Managing Director of Health Care Innovation at Morgan Health, a division of JPMorgan Chase dedicated to improving employer-sponsored healthcare. In this role, she oversees initiatives focused on enhancing quality, equity, and affordability in healthcare delivery.

Friedman leads Morgan Health’s innovation team, managing pilots, data analytics, and research efforts aimed at transforming healthcare models. Her work emphasizes the integration of data and technology to empower employees in making informed healthcare decisions and advocates for collaboration between employers and providers to enhance healthcare strategies. She also addresses the unique challenges faced by small and medium-sized businesses in accessing quality healthcare options .

Prior to her tenure at Morgan Health, Friedman held significant roles in healthcare policy and strategy. She was involved in shaping Medicare and Medicaid policy at the Center for Medicare & Medicaid Innovation (CMMI) and led health system strategy at the Advisory Board Company .

Friedman’s expertise in value-based care and employer-provider collaboration positions her as a key figure in efforts to reform the U.S. healthcare system, particularly in the context of employer-sponsored insurance.

Robbie brings a unique combination of quantitative intellect, an open mindset, exceptional communication skills, and a collaborative and deeply people focused approach to the companies he leads. With a broad and diverse educational and experience background, he is widely regarded as a collaborator, mentor, and gifted strategist who can take complex scenarios and solutions and break them down into straight forward explanations.

Currently the CEO of US Heart and Vascular (an Ares and Rubicon backed cardiology platform), Robbie has led organizations ranging from entrepreneurial start-ups to billion-dollar enterprises, and he has a long history of successfully helping those companies grow and scale nationally and globally.  In the boardroom he is passionate about mentoring executives, so their abilities and insight grow with the organization and foster continued success.

Robbie has focused his thought leadership on constructing, mentoring, and empowering teams and mentoring people in ways that drive capable leadership and power durable results. His undergraduate degree is in psychology, and he has graduate degrees in business (finance), neuroscience, and engineering (cybersecurity) with an additional graduate certificate in public policy.  He is a lifelong learner with a passion for challenging his own mindset and remaining aware of what is next.  Robbie is an avid sailor, diver, and lover of travel and the outdoors, and he and his wife share a blended family of 9 children and one grandchild and live in Nashville, TN.

Sam Hallowell leads the national emerging middle market healthcare services practice in J.P. Morgan’s Commercial Bank. J.P. Morgan is deeply committed to the sector, with a team of healthcare bankers dedicated to delivering comprehensive financial services solutions including treasury, credit, capital markets, investment banking and strategic advisory to healthcare services platforms around the United States. With a significant investment in industry-specific tools to optimize commercial and patient receivables and delivery of strategic capital, the healthcare services team at J.P. Morgan supports our industries best platforms delivering the best patient care in the world.

Sam Holliday is the Co-Founder and Chief Executive Officer of Oshi Health, a pioneering virtual gastrointestinal (GI) care company dedicated to transforming digestive healthcare through a patient-centered, multidisciplinary approach. Motivated by personal experiences—his mother’s struggle with irritable bowel syndrome (IBS) and a family member’s challenges with Crohn’s disease—Holliday established Oshi Health to provide accessible, whole-person care for individuals with chronic GI conditions.

Under Holliday’s leadership, Oshi Health has developed a virtual clinic model that integrates gastroenterologists, dietitians, behavioral health specialists, and nurse practitioners to deliver coordinated, evidence-based care. This innovative approach has led to national-scale value-based care contracts, demonstrating improved clinical outcomes, enhanced patient satisfaction, and reduced healthcare costs.

Before founding Oshi Health, Holliday held leadership roles in various healthcare technology and services companies, focusing on population health and digital health solutions. He earned a Bachelor of Science in Engineering from the University of Pennsylvania and an MBA in Healthcare Management from the Wharton School.

Beyond his role at Oshi Health, Holliday contributes to the broader healthcare landscape through his involvement with organizations like the Health Care Transformation Task Force and the V1C Coalition by DiMe, advocating for the advancement of digital medicine and value-based care models.

Residing in New York City, Holliday continues to lead Oshi Health’s mission to revolutionize GI care, aiming to alleviate the burden of digestive diseases for millions across the United States.

Seth Harlem is the Co-Founder and Chief Executive Officer of Thema Brain Health, a Boca Raton, Florida-based healthcare company specializing in the early detection and prevention of cognitive decline and Alzheimer’s disease. Under his leadership, Thema has introduced innovative tools such as ApoE Aware, an at-home genetic test that assesses Alzheimer’s risk and provides personalized prevention plans through telehealth consultations.

Harlem co-founded Thema Brain Health in 2022 alongside Dr. Robert Colton, a seasoned healthcare entrepreneur known for establishing MDVIP and ClearlyDerm. Their collaboration aims to shift the paradigm in cognitive healthcare by emphasizing proactive monitoring and intervention, akin to managing chronic conditions like hypertension or diabetes.

Prior to Thema, Harlem served as CEO of Taithera, Inc., a nanomedicine company focused on bone-targeted drug delivery for musculoskeletal conditions and bone cancers. His entrepreneurial journey includes participation in ELabNYC, a competitive life sciences accelerator program, where he honed his expertise in healthcare innovation.

In recognition of his contributions to healthcare, Harlem was named one of SCALE Healthcare’s Top 60 Most Influential Leaders in 2025.

Through his ventures, Harlem continues to advocate for integrating technology and personalized care to enhance patient outcomes in cognitive health.

Steve Straus serves as the President of ADVENT, a healthcare organization specializing in ear, nose, and throat (ENT) services. Based in Milwaukee, Wisconsin, ADVENT focuses on providing innovative treatments for sinus and sleep-related issues. Under Straus’s leadership, the organization emphasizes patient-centered care, aiming to improve the quality of life for individuals suffering from chronic ENT conditions.

In recognition of his contributions to the healthcare industry, Straus was named among SCALE Healthcare’s Top 60 Most Influential Leaders in 2025.

Sudeep Singh Bath is the Founder and Chief Executive Officer of HealthArc, a digital health company based in Hackensack, New Jersey. Established in 2021, HealthArc offers a unified platform for virtual care delivery, encompassing services such as Remote Patient Monitoring (RPM), Chronic Care Management (CCM), Principal Care Management (PCM), and Behavioral Health Integration (BHI) .

With over 22 years of experience in sales and technology leadership, Bath previously served as a Senior Vice President for a $37 billion private equity portfolio company. He has also been an advisor and board member for several startups .

Under Bath’s leadership, HealthArc has secured $5 million in growth funding to enhance its continuous care solutions . The platform integrates with over 50 medical devices and more than 20 electronic medical records (EMRs), streamlining virtual care management for providers, payers, and employers .

Bath’s vision for HealthArc focuses on simplifying virtual care delivery, improving patient outcomes, and optimizing reimbursement processes through a scalable and compliant platform.

Ted started with Unity MSK in October, 2021 as the Chief Operating Officer.  Ted was promoted to Chief Executive Officer in January of 2023.  He has 20+ years of experience as a multi-site healthcare operator with expertise in building profitable, scalable, multi-location healthcare services businesses with a strong customer service orientation/culture.  He previously led Concentra Urgent Care, the $1B+ national occupational health and urgent care provider, through multiple stages of growth and transitions in ownership.  He subsequently guided Solis Mammography through a high-growth phase that resulted in their exit from the Audax Group in 2018.  Ted has driven revenue acceleration and EBITDA growth by building exceptional teams, cost-effective infrastructure, exceptional operational consistency and enhancing customer loyalty.  Ted adds value to organizations by solving operational challenges with effective leadership and building cultures of integrity, accountability and fairness.

Ted’s track record demonstrates his ability to operate effectively in companies that have varying levels of EBITDA.   At both Concentra and Solis, Ted led teams that consistently exceeded same-store revenue growth and EBITDA targets while also building the process and outcomes metrics necessary to integrate over 300 acquisition, joint venture and denovo locations.

Vic Schmerbeck is the Chief Executive Officer at Emerus, the nation’s first and largest operator of small-format neighborhood hospitals. In his role, Vic is focused on the company’s health system partnerships, market penetration and clinical service lines in over 40 existing health system-partnered hospitals. He leads more than 2,000 employees and oversees the overall growth and strategy development of Emerus’ business, working to provide the highest quality patient care with empathy and integrity.

Vic has more than 10 years of leadership experience in the health care industry and over 20 years of investment and merchant banking experience in health care. He earned a bachelor’s degree in finance and real estate from Southern Methodist University. He has served on the board of directors for several private companies, and he is active with numerous charitable endeavors involved in healthcare and at-risk children.

Experienced Chief Operating Officer with a demonstrated history of working in the hospital & health care industry. Skilled in Healthcare Management, Healthcare, Strategic Planning, Healthcare Information Technology (HIT), and Electronic Medical Record (EMR). Strong operations professional with a Bachelor’s degree focused in Business Administration and Management, General from New York Institute of Technology.

Wyatt Ritchie is a Managing Director and the Head of Cain Brothers.  Wyatt assumed leadership in 2023 and is only the fourth leader of Cain Brothers since its founding in 1982.  Wyatt joined the firm in 2010 with over 20 years’ experience advising both public and private companies in a variety of merger and acquisition, capital raising, and strategic advisory transactions.  Prior to his current role, he focused on mergers & acquisitions and capital raising for clients in the physician practice management, multi-site healthcare services and post-acute care sectors.  He was also a member of the Firm’s Senior Management Team.  Select and recent transactions include TPG Growth’s joint venture partnership with Novant Health to expand MedQuest Associates, the sale of Cranial Technologies, Illinois Retina Associates’ affiliation with Retina Consultants of America, and the sale of Physicians Immediate Care to WellNow Urgent Care.

Prior to joining Cain Brothers, Wyatt was at Jefferies & Company, responsible for that firm’s healthcare services practice. Prior to joining Jefferies, Wyatt was at CIBC Oppenheimer for eight years where he was responsible for that firm’s West Coast healthcare services investment banking practice and at Bank of America, where he was responsible for Bank of America’s healthcare leverage finance business.

Wyatt earned BA in Economics from St. Olaf College and an MBA in Finance from the University of Chicago.